ENXTAM:DSFIRChemicals
Assessing DSM-Firmenich (ENXTAM:DSFIR) Valuation After Prolonged Share Price Weakness
Recent share performance puts DSM-Firmenich in focus
DSM-Firmenich (ENXTAM:DSFIR) has come onto investors’ radar after a series of weak returns, including an 18% decline over the past 3 months and a 41% negative total return over the past year.
See our latest analysis for DSM-Firmenich.
The recent weakness has been fairly persistent, with a 1-day share price return of a 1.91% decline and a 30-day share price return of a 17.06% decline adding to a 1-year total shareholder return of a 40.69%...